28 June, 2021 by The TZ Newswire Staff Comments Off on Why NVIDIA Stock Was Up Today
Why NVIDIA Stock Was Up Today
Shares of chipmaker NVIDIA (NASDAQ: NVDA) were up on Monday after competitor Broadcom (NASDAQ: AVGO) came out in support of the company’s proposed acquisition of U.K. chip designer Arm. NVIDIA also announced a new partnership with Alphabet‘s (NASDAQ: GOOG)(NASDAQ: GOOGL) Google to create an artificial intelligence (AI) and 5G innovation hub. Shares were up by about 5% as of 11:48 a.m. EDT today.
Image source: Getty Images.
28 June, 2021 by The TZ Newswire Staff Comments Off on Internet Computer (ICP) logs revenge recovery after crashing 95% since launch
Internet Computer (ICP) logs revenge recovery after crashing 95% since launch
The long-awaited rebound came as the community accused the Internet Computer team of dumping $6 billion worth of ICP tokens.
28 June, 2021 by The TZ Newswire Staff Comments Off on China’s Oldest Exchange Exits Bitcoin Business Amidst Regulatory Pressures
China’s Oldest Exchange Exits Bitcoin Business Amidst Regulatory Pressures
read more
28 June, 2021 by The TZ Newswire Staff Comments Off on NHC Monitoring Two Atlantic Basin Disturbances And One Hurricane In Eastern Pacific
NHC Monitoring Two Atlantic Basin Disturbances And One Hurricane In Eastern Pacific
NHC Monitoring Two Atlantic Basin Disturbances And One Hurricane In Eastern Pacific
The National Hurricane Center (NHC) is tracking multiple weather disturbances forming in the Atlantic basin and a hurricane in the Eastern Pacific.
Beginning in the Atlantic, where a disturbance is located about 190 miles east-southeast of Hilton Head Island, South Carolina, has about 70% odds of tropical cyclone formation over the next 48 hours.
28 June, 2021 by The TZ Newswire Staff Comments Off on Why Beam Therapeutics Jumped Today
Why Beam Therapeutics Jumped Today
Beam Therapeutics (NASDAQ: BEAM) was up 14% midday Monday on the back of Intellia Therapeutics‘ (NASDAQ: NTLA) phase 1 data for its therapy to treat a genetic liver disorder.
All of the companies associated with the gene-editing technique are having a good day thanks to the data. Although the treatment for the fatal disease — transthyretin (ATTR) amyloidosis — is great news, the implications go far beyond any one disease.
28 June, 2021 by The TZ Newswire Staff Comments Off on Why Editas Medicine Stock Is Jumping Today
Why Editas Medicine Stock Is Jumping Today
Shares of Editas Medicine (NASDAQ: EDIT) were jumping 7% as of 11:53 a.m. EDT on Monday after rising as much as 20.2% earlier in the day. The gain came after another CRISPR-focused biotech, Intellia Therapeutics (NASDAQ: NTLA), announced encouraging interim data over the weekend from a phase 1 study of NTLA-2001 in treating rare genetic disease transthyretin (TTR) amyloidosis.
28 June, 2021 by The TZ Newswire Staff Comments Off on UK health secretary Javid: We see no reason to go beyond July 19
UK health secretary Javid: We see no reason to go beyond July 19
UK health secretary: Covid curbs two and on July 19
UK health secretary Javid to House of Commons says:
However, hospitalizations and death rates remain relatively low.